Registry Study on Rare Cancers in Korea

NCT06746766 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-04-30

No results posted yet for this study

Summary

This study aims to determine the participation rate of patients with registered rare cancers in clinical research.

Conditions

  • Rare Cancer

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Hyo Song Kim, MD, Ph.D · Yonsei Cencer center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2027-12-01
Completion
2027-12-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06746766 on ClinicalTrials.gov